Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally.
Alkermes stock last closed at $24.65, up 1.61% from the previous day, and has decreased 15.52% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.05 percentage points. Alkermes stock is currently +11.99% from its 52-week low of $22.01, and -26.88% from its 52-week high of $33.71.
There are currently 167.08M shares of ALKS outstanding. The market capitalization of ALKS is $4.12B. In the last 24 hours, 1.68M ALKS shares were traded.
How to Buy Alkermes Stock
Not sure how to invest in Alkermes stock? Here's how.
Figure out where to buy Alkermes stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Alkermes stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Choose your method of payment and add your info.
Research Alkermes stock: The Alkermes ticker symbol is ALKS. Is Alkermes stock a good investment? Should you buy shares of ALKS? How do ALKS's underlying business fundamentals look? Do top analysts think Alkermes is a good buy? Why has ALKS's stock price moved recently? (Hint: Our stock market research tools can help you decide if ALKS is a good stock to buy).
Place your ALKS purchase: Decide if you will purchase ALKS shares at the current market price or use a limit order to purchase ALKS shares at a specific price.
Get notifications regarding your ALKS investment: Create a watchlist to key updates about your investment in Alkermes stock.
Step 1: Figure out where to buy Alkermes stock
You will need a brokerage account to access the NASDAQ market and buy ALKS stock.
A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to invest in ALKS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Alkermes stock
After you have chosen the best place to buy Alkermes stock, it's very important to evaluate their stock before you invest, so you actually wrap your head around the risk and opportunity.
Alkermes stock data
ALKS Price
$24.65
1w %
2.67%
1y %
-15.52%
5y %
-29.06%
P/E
11.52x
P/B
3.42x
P/S
2.46x
PEG
N/A
Revenue
$1.66B
Earnings
$355.76M
Fore. Rev. Growth
-2.53%
Fore. Earn. Growth
-1.1%
Market Cap
$4.12B
Next Earnings
May 1, 2024
Next Dividend
N/A
ALKS Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
ALKS profit margin has gone up from -14.2% to 21.4% in the past year.
There are more short-term assets than long-term liabilities on the ALKS balance sheet.
ALKS earnings of $281.15M is not enough to cover its interest payments.
There are more short-term assets than short-term liabilities on the ALKS balance sheet.
ALKS's operating cash flow of $401.35M allows it to safely service it's debt of $372.19M.
Negative Health Checks:
Total ALKS debt is higher than 5 years ago, relative to shareholder equity.
ALKS has a relatively high debt to equity ratio of 0.78.
Do Wall Street analysts think it's a good time to buy ALKS stock
Out of 8 sell side analysts who give ratings on ALKS, the consensus analyst rating on ALKS is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent ALKS Analyst Upgrades/Downgrades
Jason Gerberry, a top 17% analyst from Bank of America maintains ALKS with a hold rating and raises their ALKS price target from $27.00 to $29.00, on Jan 2, 2024.
Jessica Fye, a top 12% analyst from JP Morgan reinstates ALKS with a hold rating and announces their ALKS price target of $33.00, on Nov 20, 2023.
Uy Ear, a bottom 11% analyst from Mizuho maintains ALKS with a strong buy rating and lowers their ALKS price target from $37.00 to $35.00, on Oct 26, 2023.
Last year, ALKS revenue was $1.66B. Over the past 5 year, ALKS's revenue has grown by 8.74% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.89%.
What are ALKS executives and large shareholders up to?
Over the last 12 months, executives and large shareholders at ALKS have sold more shares than they have bought.
Christian Todd Nichols, SVP Chief Commercial Officer of ALKS, was the latest ALKS insider to sell. They sold $292,738.53 worth of ALKS stock on Mar 18, 2024.
Alkermes pays a dividend of 4.34%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 3.61%. If you owned $1,000 worth of ALKS stock, you would have received $43.41 in the past year.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your ALKS purchase
There are two primary options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open button and your broker will place the order.
If you want more assistance buying stocks on eToro, watch the helpful video below:
As of Apr 24, 2024, it costs $24.65 to buy one share of Alkermes stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.406 shares of ALKS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.